Clinical Trial Update: Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update reports long-term outcome predictions for duloxetine in social anxiety disorder. The study has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Anxiety Disorder | Phase 3 | Status: COMPLETED | Results posted: 2012-06-07